EP11.01. ICTIS: A Novel Scoring System to Assess the Inclusivity of Metastatic Non-Small-Cell Lung Cancer Immunotherapy Trials - PDF(Abstract)
Back to course
Pdf Summary
Asset Subtitle
Nagashree Seetharamu
Meta Tag
Speaker Nagashree Seetharamu
Topic Metastatic NSCLC: Immunotherapy - Biomarker
immunotherapy trials
eligibility criteria
access to immunotherapy
clinical trials
disparities in healthcare outcomes
broaden eligibility criteria
risk profiles
patient access
Powered By